The problem. The human genome sequence told us the letters, but most of it doesn’t code for protein. What is the rest doing? Which stretches are promoters, enhancers, transcription-factor binding sites, or regions of open chromatin — and in which cell types? Sequence alone doesn’t say.

The idea. ENCODE was an industrial-scale annotation effort: ChIP-seq, DNase-seq, RNA-seq and more across many cell lines, integrated into genome-wide maps of functional elements. Its headline — that a large fraction of the genome shows some biochemical activity — was widely debated, but the lasting product is the atlas of regulatory annotations itself.

Why it matters. ENCODE is infrastructure. When SnpEff or a downstream filter asks whether a non-coding variant lands in a regulatory element, the answer traces back to catalogues like this. It’s also the conceptual backdrop for the ATAC-seq and TF papers alongside it today — the “function” that accessibility and binding assays measure is the function ENCODE set out to map.

Verdict. Foundational as a resource; read the summary for the framing and treat the “80% functional” claim as the cautionary tale it became. The enduring value is the reference tracks, not the press release.